112 related articles for article (PubMed ID: 9525473)
1. Vitronectin decreases microvascular endothelial cell apoptosis.
Isik FF; Gibran NS; Jang YC; Sandell L; Schwartz SM
J Cell Physiol; 1998 May; 175(2):149-55. PubMed ID: 9525473
[TBL] [Abstract][Full Text] [Related]
2. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
Erdreich-Epstein A; Shimada H; Groshen S; Liu M; Metelitsa LS; Kim KS; Stins MF; Seeger RC; Durden DL
Cancer Res; 2000 Feb; 60(3):712-21. PubMed ID: 10676658
[TBL] [Abstract][Full Text] [Related]
3. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.
Uhm JH; Dooley NP; Kyritsis AP; Rao JS; Gladson CL
Clin Cancer Res; 1999 Jun; 5(6):1587-94. PubMed ID: 10389948
[TBL] [Abstract][Full Text] [Related]
4. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
[TBL] [Abstract][Full Text] [Related]
5. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro.
Hall H; Baechi T; Hubbell JA
Microvasc Res; 2001 Nov; 62(3):315-26. PubMed ID: 11678634
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix.
Li J; Zhang YP; Kirsner RS
Microsc Res Tech; 2003 Jan; 60(1):107-14. PubMed ID: 12500267
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
Delaney CE; Weagant BT; Addison CL
Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
[TBL] [Abstract][Full Text] [Related]
8. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
Santoni G; Spreghini E; Lucciarini R; Amantini C; Piccoli M
Microb Pathog; 2001 Oct; 31(4):159-72. PubMed ID: 11562169
[TBL] [Abstract][Full Text] [Related]
9. Studies on the expression of alpha(v)beta3 integrin receptors in non-malignant and malignant human cervical tumor tissues.
Chattopadhyay N; Chatterjee A
J Exp Clin Cancer Res; 2001 Jun; 20(2):269-75. PubMed ID: 11484986
[TBL] [Abstract][Full Text] [Related]
10. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
11. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc E; Strömblad S; von Schalscha TL; Mitjans F; Piulats J; Montgomery AM; Cheresh DA; Brooks PC
Cancer Res; 1999 Jun; 59(11):2724-30. PubMed ID: 10363998
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
Cao DJ; Guo YL; Colman RW
Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
[TBL] [Abstract][Full Text] [Related]
13. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells.
Mousa SA; Lorelli W; Campochiaro PA
J Cell Biochem; 1999 Jul; 74(1):135-43. PubMed ID: 10381270
[TBL] [Abstract][Full Text] [Related]
14. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
Hall H; Djonov V; Ehrbar M; Hoechli M; Hubbell JA
Angiogenesis; 2004; 7(3):213-23. PubMed ID: 15609076
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
Lee PC; Kibbe MR; Schuchert MJ; Stolz DB; Watkins SC; Griffith BP; Billiar TR; Shears LL
Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
[TBL] [Abstract][Full Text] [Related]
16. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
[TBL] [Abstract][Full Text] [Related]
19. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM
Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of integrin expression in chondrocytes during expansion for tissue engineering.
Goessler UR; Bugert P; Bieback K; Huber K; Fleischer LI; Hormann K; Riedel F
In Vivo; 2005; 19(3):501-7. PubMed ID: 15875768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
